Article Details
Retrieved on: 2021-04-15 18:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
C2i said physicians can use its technology to find trace amounts of persistent ... its platform is up to 100 times more sensitive than competing platforms.
Article found on: www.precisiononcologynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here